• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about INNPF

    Recent news which mentions INNPF

    This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
    Tickers AAWH AYRWF CGC GRAM
    Tags GRUSF AAWH SHFS
    From Benzinga
    Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth
    Tickers INNPF NEWS
    Tags Market News Cannabis INNPF
    From Benzinga
    CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
    Tickers AMZN CBD INNO INNO
    Tags Iris Bincovich Cannabis INNO
    From Benzinga
    This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
    Tickers INNO INNO INNPF NEWS
    Tags Health Care CBD and chronic pain Market News
    From Benzinga
    534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
    Tickers CBD INNO INNO INNPF
    Tags INNPF Earnings Beats Israel Cannabis
    From Benzinga
    CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
    Tickers CBD INNO INNO INNPF
    Tags INNPF CBD premium
    From Benzinga
    Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
    Tickers CFO EEX INNO INNO
    Tags TSX:LABS News Wes Getman
    From Benzinga
    More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It
    Tickers INNPF
    Tags Market News Cannabis premium
    From Benzinga
    CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare
    Tickers CBD INNPF
    Tags News Benzinga Penny Stocks
    From Benzinga
    Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales
    Tickers INNPF
    Tags Market News INNPF Commodities
    From Benzinga
    Cannabis Stock Gainers And Losers From August 25, 2023
    Tickers ACB ACRHF AGFY AKAN
    Tags MLCT VFF TSNDF
    From Benzinga
    Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
    Tickers ACRDF ACRHF AKAN AYRWF
    Tags CBWTF Cannabis CANN
    From Benzinga
    Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
    Tickers AAWH ACRDF ACRHF AGFY
    Tags OGI MGWFF MRMD
    From Benzinga
    Cannabis Stock Gainers And Losers From August 14, 2023
    Tickers ACRHF AGFY AKAN BBRRF
    Tags HEMP LVVV SNDL
    From Benzinga
    Cannabis Stock Gainers And Losers From August 11, 2023
    Tickers AAWH ACRHF AGFY ALID
    Tags JUSHF HERTF CURLF
    From Benzinga
    Innocan Pharma Secures $1.4M Via Private Placement
    Tickers INNPF
    Tags INNPF Markets Penny Stocks
    From Benzinga
    Innocan Pharma To Secure Up To $3M Via Private Placement Of Units At A 9% Prime Above Share Price
    Tickers INNPF
    Tags Penny Stocks News Benzinga
    From Benzinga
    Cannabis Stock Movers For July 21, 2023
    Tickers ACB ALID AYRWF BBRRF
    Tags Movers CURR TGIFF
    From Benzinga
    Innocan Pharma Q1 Revenue Grows 500%, Here Is What You Need To Know
    Tickers INNPF
    Tags premium Cannabis Market News
    From Benzinga
    Innocan Pharma FY22 Revenue Grows 1205% To $2.6M, Here Is What You Need To Know
    Tickers INNPF
    Tags Penny Stocks Benzinga News
    From Benzinga
    Can Liposomal CBD Injection Help Dogs With Polyarthritis? Innocan Pharma Reports Clinical Success
    Tickers INNPF
    Tags Market News Cannabis premium
    From Benzinga
    Innocan Pharma Q3 Revenue Grows 700% YoY, Here Is What You Need To Know
    Tickers INNPF
    Tags Iris Bincovich premium Market News
    From Benzinga
    4 CBD Stocks in the Canadian Capital Market
    Tickers INNPF
    Tags Guest Post Partner Content Market News
    From Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.